These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 19935700)
1. p53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesis. Post SM; Quintás-Cardama A; Terzian T; Smith C; Eischen CM; Lozano G Oncogene; 2010 Mar; 29(9):1260-9. PubMed ID: 19935700 [TBL] [Abstract][Full Text] [Related]
2. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53. Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149 [TBL] [Abstract][Full Text] [Related]
3. p21 delays tumor onset by preservation of chromosomal stability. Barboza JA; Liu G; Ju Z; El-Naggar AK; Lozano G Proc Natl Acad Sci U S A; 2006 Dec; 103(52):19842-7. PubMed ID: 17170138 [TBL] [Abstract][Full Text] [Related]
4. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development. Eischen CM; Alt JR; Wang P Oncogene; 2004 Nov; 23(55):8931-40. PubMed ID: 15467748 [TBL] [Abstract][Full Text] [Related]
9. Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice. Liu G; Parant JM; Lang G; Chau P; Chavez-Reyes A; El-Naggar AK; Multani A; Chang S; Lozano G Nat Genet; 2004 Jan; 36(1):63-8. PubMed ID: 14702042 [TBL] [Abstract][Full Text] [Related]
10. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways. Meng X; Carlson NR; Dong J; Zhang Y Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025 [TBL] [Abstract][Full Text] [Related]
12. Loss of p73 promotes dissemination of Myc-induced B cell lymphomas in mice. Nemajerova A; Petrenko O; Trümper L; Palacios G; Moll UM J Clin Invest; 2010 Jun; 120(6):2070-80. PubMed ID: 20484818 [TBL] [Abstract][Full Text] [Related]
13. IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis. Vecchio E; Golino G; Pisano A; Albano F; Falcone C; Ceglia S; Iaccino E; Mimmi S; Fiume G; Giurato G; Britti D; Scala G; Quinto I Cell Death Dis; 2019 Apr; 10(4):320. PubMed ID: 30975981 [TBL] [Abstract][Full Text] [Related]
14. Regulation of the Arf tumor suppressor in Emicro-Myc transgenic mice: longitudinal study of Myc-induced lymphomagenesis. Bertwistle D; Sherr CJ Blood; 2007 Jan; 109(2):792-4. PubMed ID: 16968893 [TBL] [Abstract][Full Text] [Related]
15. The role of p21(waf1/cip1) and p27(Kip1) in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma. Newbold A; Salmon JM; Martin BP; Stanley K; Johnstone RW Oncogene; 2014 Nov; 33(47):5415-23. PubMed ID: 24292681 [TBL] [Abstract][Full Text] [Related]
16. Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence. Reimann M; Lee S; Loddenkemper C; Dörr JR; Tabor V; Aichele P; Stein H; Dörken B; Jenuwein T; Schmitt CA Cancer Cell; 2010 Mar; 17(3):262-72. PubMed ID: 20227040 [TBL] [Abstract][Full Text] [Related]
17. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss. Baudino TA; Maclean KH; Brennan J; Parganas E; Yang C; Aslanian A; Lees JA; Sherr CJ; Roussel MF; Cleveland JL Mol Cell; 2003 Apr; 11(4):905-14. PubMed ID: 12718877 [TBL] [Abstract][Full Text] [Related]
18. Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis. Nilsson LM; Keller UB; Yang C; Nilsson JA; Cleveland JL; Roussel MF Oncogene; 2007 May; 26(20):2833-9. PubMed ID: 17099725 [TBL] [Abstract][Full Text] [Related]